Theralase Technologies Inc. V.TLT

Finally! Easy to parse data!

[DJDawg]

The way they present the data in the MD and A is the way they should have presented it in the news release...and ever time before. Finally!

Here for ease of access

All and optimized

https://postimg.cc/cgj6nLHM

Evaluable

https://postimg.cc/cgj6nLHM

[Rumpl3StiltSkin]

They do seem to be improving on the data. Even that PR on April 5 was better than prior. Vera's doing no doubt.

[riverrrow]

Thanks for the post DJDawg.  What I really like about the trial data so far is that the 5 patients that were CR at 360 days were still CR at 450 days.  Seems like wonderful news for the patients, some peace of mind once they reach 360 days.  GLTA.

[LaserStock29]

Any chance of the stock price going back up before agm? Novartis bought Endocyte for 2.1b in 2018 for its radionucleotide. I hope Novartis buys us out to build out their oncology division ... I hope that's what Vera is really here for. I pray we don't do another pp. We need a grant or some non dilutive funding . Not stories of how great our tech is in saving the canadian system with our

[DJDawg]

Agree. Seems like 360 days and no recurrence, you are good to go. So for our purposes I would consider any that have reached 360 as being almost countable as a permanent cure. Makes sense that if you have had 1-2 treatments and nothing has shown up on cytology OR cystocscope by 1 yrs, that it is gone. I know that won't be the FDA's thinking but it is nice info for us to keep in our minds.

[LaserStock29]

it was 360 day only until some slyness crept in for 450 day...... especially for photodynamics.. theres no business really doing evaluation at 450day..  Personally i think it's more becuase they want to see 3 checks after the 180day 2nd treatment if it was just one dose ... it would be 360 day ... imho Do we really have 21 patients at 450 or is that a fraction of a percentage?

[Rumpl3StiltSkin]

I believe that is the correct way to look at this Laser. :-)

[Rumpl3StiltSkin]

The data is already coming in much better Laser. Much easier to convince an Angel investor to buy at market to boost SP. Or, find an extra $ Million ot two in a drawer somewhere. They need to extend the warrants maybe? But only maybe. Should have news out this Summer on GLP, Covid animal models, and this data will be coming in and improving, so maybe with 21 evaluable already that is enough to go

[robertshaw]

I don't think we need to extend the pending expiration warranties of the 3.1 million shares, as Rogers has no intention to raise fund around such low level....

[ScienceFirst]

At this point in time, and given how disruptive this technology is, you don't go with an angel investor.  This was true in 2010-2016.  Not now.  What you need is one that opens the doors.  Just not bring money.  That's the way it works at this stage.   So we are at a stage where we jv with a big pharma, given how close we are to Breakthrough designation and

[enriquesuave]

The Best part is that in the Optimized group, they went from April 5th:  at 180 days 40.7% CR and 18.5% PR= totals responders 59.2% April 29  at 180 days  53% CR  and 24% PR= total responders 76%-77% competition Vicinium was 28% CR at 180 days  we are double plus 24% PR who can possibly convert to CR and increase CR of 53% even more.   Recent suggestions by

[prophetoffact]

This post has been removed in accordance with Community Policy

[prophetoffact]

This post has been removed in accordance with Community Policy

[patience69]

Very true prophet and dont we all think that big pharma sees that too ?

[fecats]

Absolutely. Roger et al have done a remarkable job getting us to where we are today but I think it is time to let the big boys take it to where it belongs. More lives could be preserved sooner 

[enriquesuave]

You posted the chart of All treated patients which includes 1st set of 12 who were severely undertreated.  Data is still amazing IMO even with this group.  I was referring to the Optimized group.  The chart just under the one you posted  on Sedar.

[enriquesuave]

[ScienceFirst]

EnriqueSuave ... Great input. Trailblazing! Data will prevail and act as an eye-opener.  Our results are such a giant leap, when compared to the tiny little baby-steps done over the last 40 years.  In fact, not a single agent has been able to displace BCG so far!  They're still teaming up with BCG!!!  Even Keytruda, the biggest drug seller in medicine, has not